In addition, the NADK I90F mutation has been found to exhibit higher enzymatic activity in pancreatic cancer, and by altering tumor redox homeostasis, it regulates pancreatic cancer progression21. This evidence concerns the gene NADK and familial pancreatic carcinoma.